Cilfa Opposition, Rosuvastatin, (P000100408)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, benzoilguanidinas (Markush), (P990106043)
Countries: Argentina Date: 2003
-
CILFA opposition, semaglutide, (AR114353A1)
Countries: Argentina Date: 2021
-
CILFA opposition, dapagliflozin-empagliflozin-insulin, (AR112015A1)
Countries: Argentina Date: 2019
-
CILFA opposition, trelagliptin, (AR109064A2)
Countries: Argentina Date: 2019
-
CILFA opposition, LIXISENATIDE, (AR103415A1)
Countries: Argentina Date: 2017
-
CILFA opposition, carvedilol+hydrochlorothiazide, (P990105974)
Countries: Argentina Date: 2002
-
CILFA opposition, Nadifloxacin, (P990106490)
Countries: Argentina Date: 2002
-
CILFA opposition, fexofenadine+cyclodextrins, (P990105185)
Countries: Argentina Date: 2002
-
CILFA opposition, descarboetoxiloratadina, (P000103667 divisional of P990103342)
Countries: Argentina Date: 2002
-
CILFA opposition, descarboetoxiloratadina + fosfatodibásico de calcio, (P000103668 divisional of P990103342)
Countries: Argentina Date: 2002